about
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosisHeterogeneity in tuberculosis pathology, microenvironments and therapeutic responsesInteraction of Mycobacterium tuberculosis with host cell death pathwaysLow doses of imatinib induce myelopoiesis and enhance host anti-microbial immunityNew tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeuticsCytokine and lipid mediator networks in tuberculosisMyeloid Sirtuin 2 Expression Does Not Impact Long-Term Mycobacterium tuberculosis Control.The White-Nose Syndrome Transcriptome: Activation of Anti-fungal Host Responses in Wing Tissue of Hibernating Little Brown Myotis.Inflammatory signaling in human tuberculosis granulomas is spatially organized.Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household ContactsAdventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma.Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a reviewOhr plays a central role in bacterial responses against fatty acid hydroperoxides and peroxynitrite.Inflammation and tuberculosis: host-directed therapies.Downregulation of vimentin in macrophages infected with live Mycobacterium tuberculosis is mediated by Reactive Oxygen Species.Understanding the pathophysiology of the human TB lung granuloma using in vitro granuloma models.Regulation of phagocyte triglyceride by a STAT-ATG2 pathway controls mycobacterial infection.Host-Directed Therapeutic Strategies for Tuberculosis.Controlling inflammation: a superior way to control TB.Structural insights on the efficient catalysis of hydroperoxide reduction by Ohr: Crystallographic and molecular dynamics approaches.
P2860
Q26746099-B882FA61-7FE9-4212-9583-BF516B0EF431Q26823503-CC7F9CCD-B702-441C-A611-B48648EE3076Q26852548-23D765CA-A2B3-4F88-ACBE-5985F344A6F4Q27320733-F0F2818C-861D-43FB-A989-8EC427D59F7FQ30371980-2240758B-5765-4B2A-88E5-324D6C9FF40FQ35117086-546D94EB-C7B8-4039-BBFD-02ED7D77934AQ35681218-05198C6A-8C54-46D7-9360-88CEC2D59DF1Q35794927-6DE6738E-F6A6-404B-88F1-DD20FE7C6BF2Q35979217-7719B3CD-45C1-42C9-BDDD-4219A12716F5Q36189923-56C7D9F0-EE83-4C27-9CBE-B5FD2BBACA33Q36439790-39E16AB8-57DB-4221-A66D-F856F85A14B9Q36653997-3A79B93D-B4A2-4E4A-B5AF-CA8760978ECFQ37589892-AF46F247-0A7A-4C20-8A87-0E0C44189A94Q38203352-0309401E-FD99-4E04-9CAD-6E09CACE4F84Q38432005-1A96AEA5-E267-435A-BEFA-3272E1C850FDQ38833392-B7B151A7-4966-458F-B6DB-DCDC516C2BB6Q40307073-C2565990-F264-4606-BD64-B5811B4E1554Q45006012-10A50137-59C2-4A67-B46F-BAEB3A97ACFEQ53966200-AE831FFC-806D-4D47-B8DF-54CBB062C42FQ55383654-E3AA6870-9373-44C8-9167-CEA3EB25F05F
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
TB: the Yin and Yang of lipid mediators
@ast
TB: the Yin and Yang of lipid mediators
@en
TB: the Yin and Yang of lipid mediators
@nl
type
label
TB: the Yin and Yang of lipid mediators
@ast
TB: the Yin and Yang of lipid mediators
@en
TB: the Yin and Yang of lipid mediators
@nl
prefLabel
TB: the Yin and Yang of lipid mediators
@ast
TB: the Yin and Yang of lipid mediators
@en
TB: the Yin and Yang of lipid mediators
@nl
P2860
P3181
P1476
TB: the Yin and Yang of lipid mediators
@en
P2093
David M Tobin
P2860
P3181
P356
10.1016/J.COPH.2013.06.007
P407
P577
2013-08-01T00:00:00Z